Nwam LLC Inovio Pharmaceuticals, Inc. Transaction History

Nwam LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.44 - $3.98 $23,040 - $63,680	-16,000 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$7.16 - $9.69 $1,432 - $1,938	-200 Reduced 1.23%	16,000 $115,000
Q2 2021 Aug 04, 2021	BUY	$6.23 - $10.03 $3,115 - $5,015	500 Added 3.18%	16,200 $150,000
Q1 2021 Apr 23, 2021	BUY	$8.81 - $16.96 $6,167 - $11,872	700 Added 4.67%	15,700 $146,000
Q4 2020 Jan 22, 2021	BUY	$8.5 - $12.85 $42,500 - $64,250	5,000 Added 50.0%	15,000 $133,000
Q3 2020 Oct 16, 2020	SELL	$9.57 - $27.05 $957 - $2,705	-100 Reduced 0.99%	10,000 $116,000
Q2 2020 Jul 21, 2020	BUY	$7.14 - $31.69 $72,114 - $320,069	10,100 New	10,100 $272,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $519M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

Stay updated on Nwam LLC with notifications on news.